FemmePharma Consumer Healthcare
Nancy Phelan is a seasoned executive with extensive experience in the life sciences and healthcare sectors. Currently serving as Senior Vice President at Trinity Life Sciences since May 2024, Nancy leads customer engagement solutions utilizing advanced commercial insights and technology. Additionally, Nancy holds board positions at Medexus Pharmaceuticals and FemmePharma Consumer Healthcare, contributing to strategic oversight and initiatives aimed at enhancing women's health. Past roles include Senior Vice President at Indegene, Vice President positions at Novartis, and various board memberships including Eved and HATCH@Takeda. Nancy's educational background includes a BA from Franklin & Marshall College, along with studies at Harvard T.H. Chan School of Public Health, Villanova School of Business, and Wharton Executive Education.
This person is not in any teams
This person is not in any offices
FemmePharma Consumer Healthcare
FemmePharma Global Healthcare, Inc., a pharmaceutical company, engages in developing drugs for diseases and disorders affecting women internationally. It focuses on developing therapeutic regimens for various women's health issues, such as urinary incontinence, mastalgia, dysmenorrhea, dysfunctional uterine bleeding, endometriosis, andsexually transmitted diseases/HIV. The company was founded in 1996 and is based in Wayne, Pennsylvania. FemmePharma Global Healthcare, Inc. operates as a subsidiary of FemmePharma, Inc.